Sadiqa Mahmood

Founder & CEO at Prudentia Sciences

Speaker

Sadiqa’s career has focused on identifying, evaluating and addressing areas of high unmet need across different disease areas for therapeutic development through use of technology.

A physician by training, she has practiced medicine in three continents. Most recently, she served as the President of the Count Me In program at the Broad Institute of MIT & Harvard, where she led scientific discoveries across rare cancers to drive therapeutic development. She launched the Real World Data and Real World Evidence business as General Manager and Senior Vice President at Cytel, contributing the highest number of FDA and EMA approved external control arms in Phase II and III trials. Earlier as Senior Vice President and General Manager she built the Life Sciences business at Health Catalyst (NASDAQ: HCAT), leading rapid growth from zero to $28M in three years.

Previously she led analytics, data science, quality and safety, and population health across healthcare organizations, including the Dana-Farber Cancer Institute, Mass General Brigham, and Boston Medical Center.

She holds a master’s degree in public health from the Harvard Chan School of Public Health. She spends time between Boston, MA, and Houston, TX. Outside of work, she is a Formula 1 fan and races as a member of a local team.